ask="5.01"
ask_size="100"
average_daily_volume="181187"
bid="3.94"
bid_size="4000"
book_value="0.00"
change="-0.37"
change_from_200_day_moving_average="-0.77"
change_from_50_day_moving_average="-0.59"
change_from_52_week_high="-5.71"
change_From_52_week_low="0.96"
change_in_percent="-8.45%"
close="4.01"
dividend_pay_date="8/1/2016"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.45"
ebitda="0.00"
eps_estimate_current_year="-3.64"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.25"
ex_dividend_date="N/A"
float_shares="N/A"
high="4.42"
high_52_weeks="9.72"
last_trade_date="3/14/2017"
last_trade_price="4.01"
last_trade_size="200"
last_trade_time="3:59pm"
low="4.01"
low_52_weeks="3.05"
market_capitalization="N/A"
moving_average_200_day="4.78"
moving_average_50_day="4.60"
name="Cyclacel Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="5.00"
open="4.42"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-16.15%"
percent_change_from_50_day_moving_average="-12.77%"
percent_change_from_52_week_high="-58.74%"
percent_change_from_52_week_low="+31.48%"
previous_close="4.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CYCC"
volume="45167"
weeks_range_52="3.05 - 9.72"
